Published • loading... • Updated
Nuvation Bio Announces Pricing of Upsized Offering of $250.0 million of Convertible Senior Notes
Summary by Charleston Gazette-Mail
43 Articles
43 Articles
keenesentinel.com+42 Reposted by 42 other sources
Nuvation Bio Announces Pricing of Upsized Offering of $250.0 million of Convertible Senior Notes
NEW YORK, June 25, 2026 Nuvation Bio Inc. ("Nuvation Bio") (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced the pricing of its underwritten offering (the "Offering") of $250.0 million…
Coverage Details
Total News Sources43
Leaning Left4Leaning Right3Center24Last UpdatedBias Distribution77% Center
Bias Distribution
- 77% of the sources are Center
77% Center
13%
C 77%
Factuality
To view factuality data please Upgrade to Premium
